Validation of the Turkish Version of the Modified Early Obstetric Warning Systems (MEOWS) Charts

Completed

• Conditions: Validation
• Interventions: Other: patient-administered questionnaires

• Registration Number: NCT05678920
• Lead Sponsor: Samsun Education and Research Hospital

Brief Summary

It was aimed to study MEOWS on patients in the obstetrics clinic and to evaluate the performance of this scale as a screening tool and to contribute to its usability in Turkey by translating MEOWS into Turkish.

Detailed Description

The Modified Early Obstetric Warning System (MEOWS) is a score-based or color-coded system used to detect changes in physiological parameters and enable earlier recognition and management of deteriorating patients.It was first validated by Sigh et al., then its validity and reliability were demonstrated in many countries, especially in countries with low socio-economic status.Early warning systems are not routinely used in obstetrics clinics in Turkey, and there is no Turkish version of MEOWS in the literature. In this study, it was aimed to study MEOWS on patients in obstetrics clinics and to evaluate the performance of this scale as a screening tool and to validate MEOWS by translating it into Turkish.

The study was carried out in 3 stages. The first stage is the translation of MEOWS into Turkish and its cultural adaptation, the second stage is the use of the study scale and the elimination of deficiencies by conducting a pilot study on 30 patients, and the third stage is the collection and evaluation of patient data until the specified sample size is reached.

Study Timeline

• Study Start: 2022-04-01
• Primary Completion: 2022-10-01
• Study Completion: 2022-11-01
• Status Verified: 2022-12
• Study First Submitted: 2022-12-14
• Study First Submitted QC: 2022-12-22
• Last Update Submitted: 2022-12-22
• Study First Posted: 2023-01-10
• Last Update Posted: 2023-01-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 350

Inclusion Criteria

• Obstetric patients receiving inpatient treatment in obstetrics and gynecology clinics
• Patients whose pregnancy is older than 28 weeks and between 6 weeks postpartum
• Patients who agreed to participate in the study

Exclusion Criteria

• Patients who did not agree to participate in the study
• Patients under the age of 18
• Outpatients

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Pregnant and postpartum patients	patient-administered questionnaires	Pregnant patients older than 28th gestational week and patients up to postpartum 6th week who were hospitalized in the obstetrics department

Primary Outcome Measures

Name	Time	Method
Modified Early Obstetric Warning System Chart	At the end of the study, assessed up to 1 month.	Calculation of sensitivity, specificity, positive and negative predictive value of the chart
Validation of the Modified Early Obstetric Warning System	Obstetric patients older than 28 weeks of gestation and between 6 weeks postpartum	Demonstrating the reliability and validity of the Modified Early Obstetric Warning System chart in Turkish. MEOWS chart is contained within a booklet and is commenced on admission to hospital. The same booklet is used during subsequent admissions to hospital during the relevant pregnant and postnatal period. Specific maternal observations that are recorded on the MEOWS chart are diastolic blood pressure, severity of pain, antenatal discharge and/or postnatal lochia and proteinurea. Physiological parameters which deviate from the norm are allocated a score. The score increases as deviation from the norm escalates. The final score then falls into one of three categories: a low, medium, or high score. A low score is 1-4, a medium score is 5-6 and a high score is 7 or more. Any single score of 3 indicates an extreme variation from the normal, which is considered at least a medium score. The colour prompts are green for a low score, amber for medium and red for high scores.

Trial Locations

Locations (1)

Samsun Research and Education Hospital; 🇹🇷 Samsun, Turkey